etoposide has been researched along with mofarotene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Boer-Dennert, MM; Goey, SH; Loos, WJ; Ma, J; Pronk, LC; Schellens, JH; Stoter, G; van Zuylen, L; Verweij, J | 1 |
1 trial(s) available for etoposide and mofarotene
Article | Year |
---|---|
Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Retinoids | 1999 |